Board of Governors Gene Therapeutics Research Institute
The Board of Governors Gene Therapeutics Research Institute at Cedars-Sinai is working to harness the power of the Human Genome Project to develop innovative gene therapy strategies that could cure or even prevent disease.
Gene therapy offers hope for nearly every field of medicine.
The Gene Therapeutics Research Institute's researchers, in collaboration with clinical researchers, are seeking medical advances in a wide range of clinical disorders, including:
- Parkinson's and Alzheimer's disease
- Cancers, including brain tumors; melanoma and lung cancer
- Heart disease
- Organ transplantation
- Metabolic disorders
- Intrauterine fetal disorders
- Diabetes
- Autoimmune disorders
- Chronic pain
- Infectious diseases
As one of the few facilities in the western United States capable of this type of research, Cedars-Sinai is in a unique position to help patients benefit directly from genetic research. The Board of Governors Gene Therapeutics Research Institute collaborates with other disciplines at Cedars-Sinai so that gene-based research that proves to be effective can be readily brought to medical practice by approved medical trials.
Leadership
Pedro R. Lowenstein, MD, PhD
Director, Board of Governors Gene Therapeutics Research Institute
Bram and Elaine Goldsmith Endowed Chair in Gene Therapeutics
Maria Castro, PhD
Co-Director, Board of Governors Gene Therapeutics Research Institute
Medallion's Group Endowed Chair in Gene Therapeutics
